Junfeng Lu

536 total citations
32 papers, 359 citations indexed

About

Junfeng Lu is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Junfeng Lu has authored 32 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 25 papers in Hepatology and 4 papers in Immunology. Recurrent topics in Junfeng Lu's work include Hepatitis B Virus Studies (24 papers), Hepatitis C virus research (22 papers) and Liver Disease Diagnosis and Treatment (11 papers). Junfeng Lu is often cited by papers focused on Hepatitis B Virus Studies (24 papers), Hepatitis C virus research (22 papers) and Liver Disease Diagnosis and Treatment (11 papers). Junfeng Lu collaborates with scholars based in China, United States and Hong Kong. Junfeng Lu's co-authors include Lina Ma, Shan Ren, Chengli Shen, Xinyue Chen, Zhenhuan Cao, Yi Jin, Yali Liu, Xinyue Chen, Zhongjie Hu and Zhimin He and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Junfeng Lu

29 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfeng Lu China 10 300 275 45 30 27 32 359
Ofer Ben‐Moshe Israel 7 206 0.7× 184 0.7× 46 1.0× 31 1.0× 43 1.6× 9 265
T. Gerlach Germany 6 186 0.6× 241 0.9× 75 1.7× 17 0.6× 23 0.9× 12 304
Dianhui Tan China 7 270 0.9× 268 1.0× 39 0.9× 13 0.4× 14 0.5× 10 328
P Kokordelis Germany 8 119 0.4× 159 0.6× 120 2.7× 35 1.2× 13 0.5× 13 256
Atsushi Ozasa Japan 8 264 0.9× 274 1.0× 12 0.3× 38 1.3× 62 2.3× 10 377
Daniel Kvistad United States 6 120 0.4× 103 0.4× 102 2.3× 37 1.2× 30 1.1× 7 209
Nobutoshi Komatsu Japan 9 166 0.6× 201 0.7× 45 1.0× 30 1.0× 34 1.3× 19 252
F. Stelma Netherlands 11 224 0.7× 193 0.7× 127 2.8× 31 1.0× 52 1.9× 17 356
Louis Jansen Netherlands 12 369 1.2× 312 1.1× 63 1.4× 33 1.1× 52 1.9× 22 432

Countries citing papers authored by Junfeng Lu

Since Specialization
Citations

This map shows the geographic impact of Junfeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Lu more than expected).

Fields of papers citing papers by Junfeng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Lu. The network helps show where Junfeng Lu may publish in the future.

Co-authorship network of co-authors of Junfeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Junfeng Lu. A scholar is included among the top collaborators of Junfeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfeng Lu. Junfeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoxiao, Dan Liu, Lilin Wang, et al.. (2025). CyTOF reveals platelet subtype changes predicting the efficacy of combined immunotherapy and targeted therapy in liver cancer. Frontiers in Immunology. 16. 1538652–1538652.
2.
3.
4.
Lu, Junfeng, Lian‐Shun Feng, Shiyang Shen, et al.. (2024). Sonic hedgehog-heat shock protein 90β axis promotes the development of nonalcoholic steatohepatitis in mice. Nature Communications. 15(1). 1280–1280. 9 indexed citations
5.
Liu, Yisi, Shan Ren, Lina Ma, et al.. (2024). Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function. Virology Journal. 21(1). 77–77. 4 indexed citations
6.
Liu, Yisi, Xiao Lin, Hong Li, et al.. (2023). Clinical study of hepatitis B vaccine in achieving hepatitis B surface antibody seroconversion in patients with functional cure. The Brazilian Journal of Infectious Diseases. 27(6). 103703–103703. 2 indexed citations
7.
Wang, Dongdong, Junfeng Lu, Logan K. Townsend, et al.. (2023). Fatty Acids Increase GDF15 and Reduce Food Intake Through a GFRAL Signaling Axis. Diabetes. 73(1). 51–56. 11 indexed citations
8.
Liu, Yisi, Xiao Lin, Zhenhuan Cao, et al.. (2023). Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha. BMC Endocrine Disorders. 23(1). 115–115. 4 indexed citations
9.
Song, Aixin, Yisi Liu, Zhenhuan Cao, et al.. (2022). Clinical Features and T Cell Immune Characteristics of Postpartum Hepatitis Flare in Pregnant Women With HBeAg-Positive Chronic HBV Infection. Frontiers in Immunology. 13. 881321–881321. 7 indexed citations
10.
Lin, Xiao, Hong Li, Junfeng Lu, et al.. (2022). Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance. Frontiers in Immunology. 13. 1028921–1028921. 3 indexed citations
11.
Lin, Xiao, Aixin Song, Junfeng Lu, et al.. (2022). Study on the Retreatment, Outcome, and Potential Predictors of Recurrence in Patients With Recurrence of Hepatitis B After Functional Cure. Frontiers in Immunology. 13. 879835–879835. 5 indexed citations
12.
Wang, Xiaoxiao, Aixin Song, Xiao Lin, et al.. (2022). Clinical characteristics of hepatitis flares during pregnancy and postpartum in Chinese chronic hepatitis B virus carriers—a prospective cohort study of 417 cases. Frontiers in Immunology. 13. 1031291–1031291. 9 indexed citations
13.
14.
Lin, Xiao, Jingyue Wang, Xiaomo Wang, et al.. (2021). Cost-effectiveness of combination antiviral treatment with extended duration for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B in China. Annals of Translational Medicine. 9(17). 1365–1365. 6 indexed citations
15.
Song, Aixin, Xiao Lin, Junfeng Lu, et al.. (2021). Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis. Frontiers in Immunology. 12. 779347–779347. 21 indexed citations
16.
Liu, Yali, Junfeng Lu, Zhenhuan Cao, et al.. (2019). Durability of Interferon-induced Hepatitis B Surface Antigen Seroclearance. Clinical Gastroenterology and Hepatology. 18(2). 514–516.e2. 43 indexed citations
17.
18.
Lu, Junfeng, Yali Liu, Shan Ren, et al.. (2015). Study on Post-Treatment Relapse in HBeAg Positive CHB Patients. PLoS ONE. 10(11). e0141072–e0141072. 1 indexed citations
19.
Li, Lin, Na Han, Junfeng Lu, et al.. (2012). Genetic Characterization and Transmitted Drug Resistance of the HIV Type 1 Epidemic in Men Who Have Sex with Men in Beijing, China. AIDS Research and Human Retroviruses. 29(3). 633–637. 22 indexed citations
20.
Ren, Shan, Junfeng Lu, Xiaofei Du, et al.. (2012). Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma. Cancer Immunology Immunotherapy. 61(9). 1433–1439. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ofer Ben‐Moshe Breakdown of academic impact, for papers by T. Gerlach Breakdown of academic impact, for papers by Dianhui Tan Breakdown of academic impact, for papers by P Kokordelis Breakdown of academic impact, for papers by Atsushi Ozasa Breakdown of academic impact, for papers by Daniel Kvistad Breakdown of academic impact, for papers by Nobutoshi Komatsu Breakdown of academic impact, for papers by F. Stelma Breakdown of academic impact, for papers by Louis Jansen
Rankless by CCL
2026